

AIM WINNERS & LOSERS: Cadence rises on Amapa "landmark"; ASOS dives


TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows


(Sharecast News) - Cell-based therapeutics developer ReNeuron Group updated the market on its phase 2a clinical evaluations for the treatment of the i...


UK shareholder meetings calendar - next 7 days


ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO


IN BRIEF: ReNeuron hires Swiss exec as senior independent director


TRADING UPDATES: Jet2 swings to loss; Hyve Group sees busiest quarter


EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO